journal article·2025

Bacteria biohybrids integrating anticancer peptide-loaded nanoparticles for tumor immunotherapy through pyroptosis activation

Shiyi Chen, Xunping Ouyang, Xue Wei, Gang He, Yiwen Xian, Chong Zhang, Decheng Wu

Biomaterials Science· Volume 13· Issue 22
Publisher page

Abstract

Developing bacterial-based biohybrid systems that effectively integrate tumor-targeting, immune modulation, and advanced drug delivery remains a major challenge in cancer therapy. This is primarily due to the complexities of achieving selective tumor colonization, overcoming immune clearance mechanisms, and ensuring controlled drug release within the tumor microenvironment. Here, we introduce P/L@EcN, a bacteria biohybrid system that conjugates ROS-responsive, ruxotemitide (LTX-315)-loaded poly(ethylene glycol)-block-poly(lactide-co-glycolide) (PEG-PLGA) nanoparticles (P/L-NPs) with the tumor-targeting probiotic Escherichia coli Nissle 1917 (EcN) via copper-free azide-alkyne click chemistry. This hybrid system exhibits enhanced tumor accumulation, improved cellular uptake, and deep tumor penetration, while effectively inducing pyroptosis through caspase-1-dependent pathways. In an in vivo orthotopic breast cancer model, P/L@EcN enhanced anti-tumor immunity by remodeling the tumor microenvironment, promoting the macrophage M1/M2 ratio, and reducing myeloid-derived suppressor cells (MDSCs), ultimately achieving significant tumor growth suppression without systemic toxicity. Together, these findings establish P/L@EcN as a promising biohybrid immunotherapy strategy that integrates bacterial-mediated targeting with immune activation, offering a powerful approach for cancer treatment.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cancer Research and Treatments · Nanoplatforms for cancer theranostics · Peptidase Inhibition and Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Guangdong Provincial Key Laboratory of Advanced Biomaterials, Department of Biomedical Engineering, Southern University of Science and Technology, No. 1088 Xueyuan Avenue, Nanshan District, Shenzhen, Guangdong 518055, China

Funding

National Key R&D Program of China

References (58)

Show source-provided references
1. Van Hoogstraten · Nat. Rev. Clin. Oncol. · 2023 · 20 · 28710.1038/s41571-023-00744-3 ↗
2. Boixareu · Nat. Rev. Urol. · 2025 · 22 · 56910.1038/s41585-025-01014-w ↗
3. Wang · Signal Transduction Targeted Ther. · 2024 · 9 · 20010.1038/s41392-024-01889-y ↗
4. Hasan · Mol. Cancer · 2023 · 22 · 16810.1186/s12943-023-01854-3 ↗
5. Nguyen · Nat. Nanotechnol. · 2024 · 19 · 172310.1038/s41565-024-01757-4 ↗
6. Zhou · Acc. Chem. Res. · 2020 · 53 · 176110.1021/acs.accounts.0c00254 ↗
7. Ali · Semin. Cancer Biol. · 2021 · 69 · 5210.1016/j.semcancer.2020.01.011 ↗
8. Shen · Adv. Drug Delivery Rev. · 2023 · 194 · 11470710.1016/j.addr.2023.114707 ↗
9. Yi · Signal Transduction Targeted Ther. · 2022 · 7 · 38610.1038/s41392-022-01250-1 ↗
10. Gong · Nat. Rev. Drug Discovery · 2024 · 23 · 60710.1038/s41573-024-00974-9 ↗
11. Yang · Biomaterials · 2021 · 265 · 12045610.1016/j.biomaterials.2020.120456 ↗
12. Linderman · Nat. Rev. Clin. Oncol. · 2025 · 22 · 26210.1038/s41571-025-01000-6 ↗
13. Harimoto · Nat. Rev. Mater. · 2025 · 10 · 19110.1038/s41578-024-00766-y ↗
14. Rodrigo-Navarro · Nat. Rev. Mater. · 2021 · 6 · 117510.1038/s41578-021-00350-8 ↗
15. Wu · Adv. Drug Delivery Rev. · 2022 · 188 · 11444310.1016/j.addr.2022.114443 ↗
16. Swanson · Nat. Rev. Gastroenterol. Hepatol. · 2020 · 17 · 68710.1038/s41575-020-0344-2 ↗
17. O'Toole · Nat. Microbiol. · 2017 · 2 · 1705710.1038/nmicrobiol.2017.57 ↗
18. Ma · Nat. Commun. · 2023 · 14 · 160610.1038/s41467-023-37225-1 ↗
19. Wu · Nat. Rev. Cancer · 2019 · 19 · 187
20. Wu · Nat. Commun. · 2024 · 15 · 1050310.1038/s41467-024-54883-x ↗
21. Xu · Adv. Mater. · 2023 · 35 · 230335710.1002/adma.202303357 ↗
22. Lin · Biomaterials · 2021 · 277 · 12112410.1016/j.biomaterials.2021.121124 ↗
23. Riglar · Nat. Rev. Microbiol. · 2018 · 16 · 21410.1038/nrmicro.2017.172 ↗
24. Piñero-Lambea · Curr. Opin. Biotechnol. · 2015 · 35 · 9410.1016/j.copbio.2015.05.004 ↗
25. Li · Signal Transduction Targeted Ther. · 2019 · 4 · 3510.1038/s41392-019-0070-9 ↗
26. Li · Adv. Mater. · 2021 · 33 · 210258010.1002/adma.202102580 ↗
27. Fatima · Adv. Mater. · 2024 · 36 · 231293910.1002/adma.202312939 ↗
28. Shi · Nature · 2015 · 526 · 66010.1038/nature15514 ↗
29. Shi · Trends Biochem. Sci. · 2017 · 42 · 24510.1016/j.tibs.2016.10.004 ↗
30. Broz · Nat. Rev. Immunol. · 2020 · 20 · 14310.1038/s41577-019-0228-2 ↗
31. Bai · Nat. Rev. Mol. Cell Biol. · 2025 · 26 · 50110.1038/s41580-025-00837-0 ↗
32. Liu · Nat. Rev. Drug Discovery · 2021 · 20 · 38410.1038/s41573-021-00154-z ↗
33. Wang · Cell · 2020 · 180 · 94110.1016/j.cell.2020.02.002 ↗
34. Chen · Nano Lett. · 2023 · 23 · 872510.1021/acs.nanolett.3c02728 ↗
35. Ou · Nano Lett. · 2023 · 23 · 205610.1021/acs.nanolett.2c03809 ↗
36. Liu · Trends Immunol. · 2024 · 45 · 27410.1016/j.it.2024.02.003 ↗
37. Aachoui · Science · 2013 · 339 · 97510.1126/science.1230751 ↗
38. Bedoui · Nat. Rev. Mol. Cell Biol. · 2020 · 21 · 67810.1038/s41580-020-0270-8 ↗
39. Forbes · Nat. Rev. Cancer · 2010 · 10 · 78510.1038/nrc2934 ↗
40. Zhou · Nat. Rev. Cancer · 2018 · 18 · 72710.1038/s41568-018-0070-z ↗
41. Gurbatri · Science · 2022 · 378 · 85810.1126/science.add9667 ↗
42. Luo · Nano Lett. · 2023 · 23 · 808110.1021/acs.nanolett.3c02061 ↗
43. Chen · Antibiotics · 2020 · 9 · 2410.3390/antibiotics9010024 ↗
44. Böttger · PLoS One · 2017 · 12 · e017894310.1371/journal.pone.0178943 ↗
45. Haug · J. Med. Chem. · 2016 · 59 · 291810.1021/acs.jmedchem.5b02025 ↗
46. Kuru · Angew. Chem., Int. Ed. · 2012 · 51 · 1251910.1002/anie.201206749 ↗
47. Agard · J. Am. Chem. Soc. · 2004 · 126 · 1504610.1021/ja044996f ↗
48. Jewett · Chem. Soc. Rev. · 2010 · 39 · 127210.1039/b901970g ↗
49. Kim · Chem. Sci. · 2019 · 10 · 783510.1039/C9SC03368H ↗
50. Tao · Asian J. Pharm. Sci. · 2018 · 13 · 101
51. Qiao · Nature · 2014 · 511 · 10810.1038/nature13484 ↗
52. Amin · J. Nanobiotechnol. · 2017 · 15 · 1210.1186/s12951-016-0227-4 ↗
53. Zhang · J. Controlled Release · 2014 · 183 · 7710.1016/j.jconrel.2014.03.026 ↗
54. Tsuchiya · Nat. Commun. · 2019 · 10 · 209110.1038/s41467-019-09753-2 ↗
55. Ma · Nat. Commun. · 2023 · 14 · 160610.1038/s41467-023-37225-1 ↗
56. Gurbatri · Nat. Commun. · 2024 · 15 · 64610.1038/s41467-024-44776-4 ↗
57. Zhao · Gut Microbes · 2022 · 14 · 207039110.1080/19490976.2022.2070391 ↗
58. Redenti · Nature · 2024 · 635 · 45310.1038/s41586-024-08033-4 ↗